SPORTIELLO, Liberata
 Distribuzione geografica
Continente #
NA - Nord America 1.488
EU - Europa 1.395
AS - Asia 768
SA - Sud America 60
AF - Africa 12
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.726
Nazione #
US - Stati Uniti d'America 1.474
IE - Irlanda 464
IT - Italia 329
SG - Singapore 233
HK - Hong Kong 183
CN - Cina 171
GB - Regno Unito 149
UA - Ucraina 128
DE - Germania 126
VN - Vietnam 73
BR - Brasile 56
GR - Grecia 47
FI - Finlandia 43
TR - Turchia 34
KR - Corea 25
SE - Svezia 22
FR - Francia 17
IN - India 15
BE - Belgio 13
AT - Austria 10
CA - Canada 8
CZ - Repubblica Ceca 8
ID - Indonesia 8
NL - Olanda 7
ES - Italia 6
ZA - Sudafrica 6
DK - Danimarca 5
IL - Israele 5
CH - Svizzera 4
IR - Iran 4
MA - Marocco 4
IQ - Iraq 3
PL - Polonia 3
AM - Armenia 2
AR - Argentina 2
BY - Bielorussia 2
HR - Croazia 2
JO - Giordania 2
LV - Lettonia 2
MX - Messico 2
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.726
Città #
Dublin 461
Santa Clara 265
Jacksonville 206
Hong Kong 182
Chandler 176
Singapore 77
Ann Arbor 68
Dong Ket 66
Princeton 54
Aversa 50
Beijing 49
Roxbury 48
Ashburn 47
Medford 46
Bremen 45
Woodbridge 34
Caserta 28
Wilmington 28
Düsseldorf 26
Naples 26
Seoul 23
Mountain View 21
Nanjing 20
Des Moines 17
Genoa 17
Boardman 15
Dearborn 15
Brussels 13
New York 13
Cambridge 12
Kunming 12
Milan 12
Helsinki 10
Jinan 10
Los Angeles 10
Napoli 10
Rome 10
Auburn Hills 8
Falkenstein 8
Hanover 8
Messina 8
Brno 7
Hanoi 7
Nuremberg 7
San Mateo 7
Shenyang 7
Chengdu 6
Jakarta 6
Norwalk 6
Salerno 6
Cagliari 5
Changsha 5
Hebei 5
Johannesburg 5
Nanchang 5
Redwood City 5
São Paulo 5
Venice 5
Vienna 5
Avellino 4
Giugliano in Campania 4
Hefei 4
Houston 4
Juelsminde 4
Tel Aviv 4
Toronto 4
Washington 4
Athens 3
Falls Church 3
Guangzhou 3
Guido 3
London 3
Mezzano 3
Padova 3
Palermo 3
Ribeirão das Neves 3
Santa Maria Capua Vetere 3
Secunderabad 3
Siracusa 3
Stockholm 3
Trento 3
Vadodara 3
Acerra 2
Alagoinhas 2
Amman 2
Amsterdam 2
Barcelona 2
Caivano 2
Capri 2
Carife 2
City of Westminster 2
Dallas 2
Gosport 2
Groningen 2
Grugliasco 2
Indaiatuba 2
Jiaxing 2
Krems 2
La Jolla 2
Lagoa Santa 2
Totale 2.471
Nome #
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 114
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 107
Adverse drug reactions and gender differences: What changes in drug safety? 103
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 95
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 93
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 90
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 89
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 86
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 86
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 85
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 84
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 82
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 82
Complete resistance after maximal dose of rocuronium 74
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 69
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 69
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 68
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 68
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 67
Disclosing negative trial results – procedure 66
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 65
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 64
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 64
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 63
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 59
DPP-4 inhibitors: Pharmacological differences and their clinical implications 58
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 57
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 55
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 54
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 52
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin. 50
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 49
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 49
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 48
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 48
Current pharmacological treatments for COVID-19: What's next? 48
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 47
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 47
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 46
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 45
Should we abandon statins in the prevention of bone fractures? 44
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 43
Therapeutic strategies to fight COVID-19: Which is the status artis? 43
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 40
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 40
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 40
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 39
Notification of undesirable effects of cosmetics and toiletries 38
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 38
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 38
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 36
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 36
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 36
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 36
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 35
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 35
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 35
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? 33
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 33
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 33
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 32
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 31
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 29
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 29
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 26
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 24
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice 22
Neutral endopeptidase (neprilysin) 22
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 21
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 21
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 18
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 17
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 16
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 16
It is the time to change the paradigms of pregnant and breastfeeding women in clinical research! 15
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study 15
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021) 10
Sex and gender differences and pharmacovigilance: a knot still to be untied 10
Totale 3.870
Categoria #
all - tutte 18.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202078 0 0 0 0 0 0 0 0 38 16 20 4
2020/2021367 13 4 33 16 55 6 45 36 9 22 57 71
2021/2022338 9 8 2 3 123 10 12 9 15 16 22 109
2022/2023872 91 21 12 58 95 58 6 48 423 6 35 19
2023/2024424 26 10 30 23 122 27 12 48 21 16 29 60
2024/2025987 10 31 28 41 180 193 194 117 193 0 0 0
Totale 3.870